Depressive symptomatology and quality of life assessment among women using the levonorgestrel-releasing intrauterine system: an observational study

Basit Öğe Kaydı
dc.contributor.authorPekin, Aybike Tazegul
dc.contributor.authorKerimoglu, Ozlem Secilmis
dc.contributor.authorKebapcilar, Ayse Gul
dc.contributor.authorYilmaz, Setenay Arzu
dc.contributor.authorBenzer, Nilgun
dc.contributor.authorCelik, Cetin
dc.date.accessioned2020-03-26T18:49:57Z
dc.date.available2020-03-26T18:49:57Z
dc.date.issued2014
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractThe aim of our study was to examine the effect of the levonorgestrel-releasing intrauterine system (LNG-IUS) treatment on depressive symptoms, changes in bleeding patterns, and quality of life (QoL) among premenopausal women in our clinic. We recruited 120 premenopausal women, aged 18-50 years, who had sought care in the previous year for menorrhagia. LNG-IUS was inserted into eligible patients after the relevant evaluations. Both questionnaires were administered at time of the initial screening before and 6 months after insertion of the LNG-IUS. All patients completed the 36-item Short-Form Health Survey (SF-36) for QoL and Beck's Depression Inventory for depressive symptoms. At the 6-month follow-up visit, the pictorial blood assessment chart score (PBAC) considerably decreased (p < 0.001). For SF-36 scores, physical functioning, physical role limitations, emotional role limitations, bodily pain, vitality, and mental health scores improved significantly after treatment (p < 0.001). Depression scores showed no significant difference from baseline to 6 months (p = 0.375). The LNG-IUS for the treatment of menorrhagia increases the QoL, and depression scores did not increase significantly in 6 months.en_US
dc.identifier.doi10.1007/s00404-014-3237-1en_US
dc.identifier.endpage511en_US
dc.identifier.issn0932-0067en_US
dc.identifier.issn1432-0711en_US
dc.identifier.issue3en_US
dc.identifier.pmid24748280en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage507en_US
dc.identifier.urihttps://dx.doi.org/10.1007/s00404-014-3237-1
dc.identifier.urihttps://hdl.handle.net/20.500.12395/30719
dc.identifier.volume290en_US
dc.identifier.wosWOS:000340518300020en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSPRINGER HEIDELBERGen_US
dc.relation.ispartofARCHIVES OF GYNECOLOGY AND OBSTETRICSen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectLevonorgestrel-releasing intrauterine system (LNG-IUS)en_US
dc.subjectMenorrhagiaen_US
dc.subjectQuality of lifeen_US
dc.titleDepressive symptomatology and quality of life assessment among women using the levonorgestrel-releasing intrauterine system: an observational studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu